Comment from Cerebral Palsy Foundation
AnonymousSupportAdvocacy
Summary: The Cerebral Palsy Foundation (CPF) supports the FDA's Request for Information on drug repurposing and urges the agency to include cerebral palsy as a priority disease area. They recommend that the FDA support regulatory approaches for pediatric neurodevelopmental disorders and partner with disease-specific foundations to accelerate therapeutic development.
The Cerebral Palsy Foundation appreciates the opportunity to submit the attached comments to the Food and Drug Administration's Request for Information on Drug Repurposing for Unmet Medical Needs. Please do not hesitate to contact us with questions.